Analysis of Suppressor and Non-Suppressor FOXP3+ T Cells in HIV-1-Infected Patients

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Arruvito, Lourdes ^a   Sabatté, Juan ^a   Pandolfi, Julieta ^a   Baz, Plácida ^a   Billordo, Luis A ^a   Lasala, Maria B ^a   Salomón, Horacio ^a   Geffner, Jorge ^a   Fainboim, Leonardo ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSCRIPTION FACTOR FOXP3;

ACTIVATED REGULATORY T LYMPHOCYTE; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL POLARITY; CELL SELECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; REGULATORY T LYMPHOCYTE; RESTING REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; TH1 CELL; TH17 CELL; TH2 CELL; VIRUS LOAD;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; COHORT STUDIES; CYTOKINES; DISEASE SUSCEPTIBILITY; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE SUBSETS; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TISSUE DONORS; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84871417975     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052580     Document Type: Article

References (29)

1. Fontenot JD, Gavin MA, Rudensky AY, (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336.
2. Roncador G, Brown PJ, Maestre L, Hue S, Martinez-Torrecuadrada JL, et al. (2005) Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 35: 1681-1691.
3. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203: 1701-1711.
4. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, et al. (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203: 1693-1700.
5. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, et al. (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.
6. Douek DC, Picker LJ, Koup RA, (2003) T cell dynamics in HIV-1 infection. Annu Rev Immunol 21: 265-304.
7. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, et al. (2005) Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
8. Belkaid Y, Tarbell K, (2009) Regulatory T cells in the control of host-microorganism interactions (*). Annu Rev Immunol 27: 551-589.
9. Sakaguchi S, (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6: 345-352.
10. Epple HJ, Loddenkemper C, Kunkel D, Troger H, Maul J, et al. (2006) Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108: 3072-3078.
11. Eggena MP, Barugahare B, Jones N, Okello M, Mutalya S, et al. (2005) Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 174: 4407-4414.
12. Tenorio AR, Martinson J, Pollard D, Baum L, Landay A, (2008) The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection. J Acquir Immune Defic Syndr 48: 577-580.
13. Schulze Zur Wiesch J, Thomssen A, Hartjen P, Toth I, Lehmann C, et al. (2011) Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol 85: 1287-1297.
14. Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, et al. (2007) Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 21: 1525-1534.
15. Fazekas de St Groth B, Landay AL, (2008) Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? AIDS 22: 671-683.
16. Bi X, Suzuki Y, Gatanaga H, Oka S, (2009) High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts. Eur J Immunol 39: 301-309.
17. Arruvito L, Sanz M, Banham AH, Fainboim L, (2007) Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 178: 2572-2578.
18. Severe P, Juste MA, Ambroise A, Eliacin L, Marchand C, et al. (2010) Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med 363: 257-265.
19. Hammer SM, Eron JJ Jr, Reiss P, (2008) Schooley RT, Thompson MA, et al (2008) Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 300: 555-570.
20. Lundgren JD, Battegay M, Behrens G, De Wit S, Guaraldi G, et al. (2008) European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. HIV Med 9: 72-81.
21. Simonetta F, Lecuroux C, Girault I, Goujard C, Sinet M, et al. (2012) Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection. J Infect Dis 205: 1510-1519.
22. Apoil PA, Puissant B, Roubinet F, Abbal M, Massip P, et al. (2005) FOXP3 mRNA levels are decreased in peripheral blood CD4+ lymphocytes from HIV-positive patients. J Acquir Immune Defic Syndr 39: 381-385.
23. Andersson J, Boasso A, Nilsson J, Zhang R, Shire NJ, et al. (2005) The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 174: 3143-3147.
24. Baker CA, Clark R, Ventura F, Jones NG, Guzman D, et al. (2007) Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection. Clin Exp Immunol 147: 533-539.
25. Hunt PW, Landay AL, Sinclair E, Martinson JA, Hatano H, et al. (2011) A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One 6: e15924.
26. Di Mitri D, Azevedo RI, Henson SM, Libri V, Riddell NE, et al. (2011) Reversible senescence in human CD4+CD45RA+CD27- memory T cells. J Immunol 187: 2093-2100.
27. Imami N, Pires A, Hardy G, Wilson J, Gazzard B, et al. (2002) A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection. J Virol 76: 9011-9023.
28. Sousa AE, Chaves AF, Doroana M, Antunes F, Victorino RM, (1999) Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection. J Immunol 162: 3718-3726.
29. Tsunemi S, Iwasaki T, Imado T, Higasa S, Kakishita E, et al. (2005) Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients. AIDS 19: 879-886.